Cargando…
PARP1 Inhibition as a Novel Therapeutic Target for Keloid Disease
Objective: Inactivation of poly(ADP-ribose) polymerase 1 (PARP1) has been found to have protective effect in several fibrotic diseases. But the effect is not studied yet in keloids. Herein, we evaluated the therapeutic effect of PARP1 inhibitor, rucaparib, for keloids. Approach: The protein expressi...
Autores principales: | Park, Tae Hwan, Kim, Chan Woo, Choi, Jin Sik, Park, Yun Joo, Chong, Yosep, Park, Min Ji, Cho, Yuri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529855/ https://www.ncbi.nlm.nih.gov/pubmed/31119062 http://dx.doi.org/10.1089/wound.2018.0910 |
Ejemplares similares
-
Poly(ADP-ribose) Polymerase 1 Inhibition as a Novel Therapeutic Target for Keloid Disease
por: Woo Kim, Chan, et al.
Publicado: (2019) -
Could −79 °C Spray-Type Cryotherapy Be an Effective Monotherapy for the Treatment of Keloid?
por: Park, Tae Hwan, et al.
Publicado: (2017) -
Complete excision of proliferating core in auricular keloids significantly reduces local recurrence: A prospective study
por: Chong, Yosep, et al.
Publicado: (2017) -
Earrings Embedded within Earlobe Keloids
por: Park, Ji Hae, et al.
Publicado: (2013) -
Soluble Factors Released by Endogenous Viable Cells Enhance the Antioxidant and Chemoattractive Activities of Cryopreserved Amniotic Membrane
por: Duan-Arnold, Yi, et al.
Publicado: (2015)